FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

715 letters match. Newest first.

  1. K.C. Pharmaceuticals, Inc.

    FDA cited K.C. Pharmaceuticals of Pomona, CA, for sterile-drug manufacturing failures, including aseptic practice problems and failed media fills.

    High risk
  2. Auriga Research Pvt. Ltd.

    Auriga Research, an Indian contract drug testing lab, failed to keep complete lab records and properly investigate failing test results.

    High risk
  3. DeJong Family Dairy, LLC

    FDA warned DeJong Family Dairy that it treated cows with an animal drug in ways the label and a veterinarian did not allow.

    Medium
  4. Waves and Wine, Inc.

    FDA warns Waves and Wine, a California raw pet food maker, over Listeria in its beef pet foods and inadequate food safety controls.

    High risk
  5. Lico Industries, LLC., d.b.a. American Towelette Company

    FDA warns Lico Industries (American Towelette) that its OTC drug wipes are adulterated due to poor quality oversight, dirty equipment and falsified records.

    High risk
  6. Tex-Stein Dairy

    Tex-Stein Dairy sold a dairy cow for slaughter with illegal meloxicam and ceftiofur residues and kept incomplete treatment records.

    High risk
  7. Dabur India Limited

    FDA cites Dabur India for falsified records, incomplete lab data, and inadequate cleaning and process validation for over-the-counter drugs.

    High risk
  8. ABS Corporation

    ABS Corporation released out-of-specification veterinary drugs and used inadequately tested raw materials, FDA says.

    High risk
  9. Koven Technologies, Inc.

    FDA warns Koven Technologies that its Bidop 3 Doppler was labeled for fetal use without clearance and had quality system violations.

    High risk
  10. AAL Trading Inc.

    FDA warned importer AAL Trading Inc. that it had no FSVP — the required program to verify foreign suppliers — for its enoki and maitake mushrooms.

    High risk
  11. Eherbs Imports, Inc

    FDA warns Eherbs Imports it lacked required foreign supplier verification for imported bread, string cheese, and amaranth candy.

    Medium
  12. AHC Products, Inc.

    AHC Products, Inc. was cited for manufacturing-rule violations and unapproved animal drugs, including AniPrin and Rot-B-Gone.

    High risk
  13. Island Kinetics, Inc. d.b.a. CoValence Laboratories

    Island Kinetics (CoValence Laboratories) made OTC acne drugs without process validation and shipped unapproved, misbranded acne products.

    High risk
  14. Almon Healthcare Private Limited

    Almon Healthcare, an Indian active pharmaceutical ingredient (API) maker, knowingly used mislabeled, untested raw material and shipped affected drugs to the U.S.

    High risk
  15. BioMylz Pvt. Ltd.

    FDA found destroyed records, inadequate process and cleaning validation, missing microbial testing, and incomplete drug listings at BioMylz, an Indian OTC drug manufacturer.

    High risk
  16. Shimoga Chemicals

    FDA warns Shimoga Chemicals of manufacturing quality and data integrity failures in clomiphene citrate active ingredient.

    High risk
  17. indejuicevapestore.co.uk

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  18. Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd.

    FDA warned investigator Dr. Pratik Doshi at Alembic's Vadodara site that a bioequivalence study consent form wrongly said nothing was experimental.

    High risk
  19. Balkanica LLC

    FDA warns Balkanica LLC over missing foreign supplier verification program for imported Bulgarian sunflower seeds and sheep’s milk cheese.

    Medium
  20. Fareva Amboise

    FDA warned Fareva Amboise in France about sterile drug manufacturing failures, including aseptic practice and data integrity problems.

    High risk
  21. Shang Hao Jia, Inc.

    Shang Hao Jia lacked required foreign supplier verification for imported tofu, crackers and almond cake, including a recalled tofu with undeclared sesame.

    High risk
  22. International Medication Systems Limited

    FDA found insect larvae and heavy microbial growth in International Medication Systems' sterile filling area; its epinephrine injection lot was later recalled.

    High risk
  23. Diamond Distributions LLC

    Diamond Distributions LLC lacked a Foreign Supplier Verification Program for imported chocolate products, FDA found after a May 2026 inspection.

    Medium
  24. J&B Food Consulting

    J&B Food Consulting lacked a Foreign Supplier Verification Program for imported pet treats; some samples had Salmonella.

    High risk
  25. Extra Medication / www.extramedication.com

    FDA warned website Extra Medication for selling unapproved, misbranded ketamine drugs to U.S. consumers without prescriptions.

    High risk
  26. Pure Arylcyclohexylamine Store / www.arylcyclohexylamine.com

    FDA warned Pure Arylcyclohexylamine Store it sells unapproved, misbranded ketamine drugs, including an injectable, to U.S. consumers online.

    High risk
  27. Ketamine Troche Store / www.ketaminetrochestore.com

    FDA warned online seller Ketamine Troche Store that its website sells unapproved, misbranded ketamine drugs without prescriptions.

    High risk
  28. Ketamine Store / www.ketaminestore.org

    FDA warned website Ketamine Store for selling unapproved, misbranded ketamine liquid and compounded products online without prescriptions.

    High risk
  29. Excelvision - Fareva

    FDA warned Excelvision-Fareva after a 2026 inspection found inadequate contamination investigations and aseptic failures for sterile drugs.

    High risk
  30. Wizcure Pharmaa Private Limited

    FDA warned Wizcure Pharmaa about serious manufacturing and data-integrity failures in sterile OTC drugs.

    High risk
  31. Yangzhou Hongshengding Chemical Co., Ltd.

    Yangzhou Hongshengding Chemical refused FDA records requests for its over-the-counter drugs, leading to an import alert.

    High risk
  32. Life & Food Inc.

    FDA: Life & Food Inc., a Las Vegas matcha and green tea importer, had no FSVP (importer safety plan) for any food it imports.

    Medium
  33. Amazon.com, Inc.

    FDA warned Amazon that three creams sold and shipped through Fulfillment by Amazon are unapproved new drugs for phimosis and balanitis.

    High risk
  34. Great India Overseas Pvt. Ltd. dba Silkrute

    FDA warns Silkrute over unapproved new drugs sold on its website, including ProGlan, Cordiagra, and Prost Aid.

    High risk
  35. Indiangoods.shop

    FDA warned website Indiangoods.shop that three herbal sexual-performance capsules it sells are unapproved new drugs.

    Medium
  36. Huons Co., Ltd.

    FDA cites Huons in South Korea for data integrity and sterility failures in drug manufacturing.

    High risk
  37. Jubilant HollisterStier General Partnership

    FDA found sterile drug manufacturing and investigation failures at Jubilant HollisterStier in Kirkland.

    High risk
  38. HydraMed IV LLC dba HydraMed

    FDA told Denver telehealth seller HydraMed its website misbrands compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  39. Nexus Health Solutions LLC dba Harper Meds

    FDA warned telehealth seller Harper Meds that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.

    Low
  40. Pharmathen International S.A.

    FDA warns Pharmathen over inadequate aseptic controls at its Greek plant making sterile drugs for the U.S.

    High risk
  41. Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

    FDA: Hubei Gedian Humanwell API plant has scratched, stained equipment and weak quality unit oversight.

    High risk
  42. Gopaldas Visram & Co., Ltd.

    FDA warns Indian OTC drug maker Gopaldas Visram over talc asbestos testing and data integrity failures.

    High risk
  43. Umendra Life Sciences Private Limited

    Umendra Life Sciences, an Indian maker of OTC talc-containing drugs, failed CGMP on talc testing and asbestos control, FDA says.

    High risk
  44. Shantou Qiwei Industry Co., LTD

    FDA warns Shantou Qiwei, a Chinese OTC drug maker, that it never tested talc for asbestos, making its products adulterated.

    High risk
  45. Zydus Lifesciences Limited

    FDA warns Zydus Lifesciences over untested asbestos in talc used in its prescription drugs and altered lab data at its Himachal Pradesh plant.

    High risk
  46. Medline Inc

    FDA warned Medline Inc about repeated Bacillus cereus contamination in its drug products and inadequate investigations.

    High risk
  47. Aeroflex Industria de Aerosol Ltda.

    Brazil OTC drug maker Aeroflex ignored FDA records requests, prompting possible approval holds and US shipment refusals.

    High risk
  48. Alchymars ICM SM Private Limited

    FDA found Alchymars API manufacturing had poor equipment and facility maintenance, making its APIs adulterated and prompting an import alert.

    High risk
  49. Sato Pharmaceutical Co., Ltd.

    FDA says Sato Pharmaceutical's sterile OTC drug line had contamination and stability failures.

    High risk
  50. GC America, Inc.

    FDA warned GC America after an inspection found inadequate component testing, stability data, and quality oversight for its OTC drugs.

    High risk